Adenoviral-Vectored Mayaro and Chikungunya Virus Vaccine Candidates Afford Partial Cross-Protection From Lethal Challenge in A129 Mouse Model.

Saved in:
Bibliographic Details
Title: Adenoviral-Vectored Mayaro and Chikungunya Virus Vaccine Candidates Afford Partial Cross-Protection From Lethal Challenge in A129 Mouse Model.
Authors: Campos RK; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, United States., Preciado-Llanes L; Nuffield Department of Medicine, The Jenner Institute, University of Oxford, Oxford, United Kingdom., Azar SR; Department of Pathology, University of Texas Medical Branch, Galveston, TX, United States., Kim YC; Nuffield Department of Medicine, The Jenner Institute, University of Oxford, Oxford, United Kingdom., Brandon O; Nuffield Department of Medicine, The Jenner Institute, University of Oxford, Oxford, United Kingdom., López-Camacho C; Nuffield Department of Medicine, The Jenner Institute, University of Oxford, Oxford, United Kingdom., Reyes-Sandoval A; Nuffield Department of Medicine, The Jenner Institute, University of Oxford, Oxford, United Kingdom., Rossi SL; Department of Pathology, University of Texas Medical Branch, Galveston, TX, United States.; Institute for Human Infection and Immunity, University of Texas Medical Branch, Galveston, TX, United States.
Source: Frontiers in immunology [Front Immunol] 2020 Nov 04; Vol. 11, pp. 591885. Date of Electronic Publication: 2020 Nov 04 (Print Publication: 2020).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2020.591885